4.7 Article

Repairing blood-CNS barriers: Future therapeutic approaches for neuropsychiatric disorders

Journal

PHARMACOLOGICAL RESEARCH
Volume 162, Issue -, Pages -

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2020.105226

Keywords

Blood-brain barrier; Blood-cerebrospinal fluid barrier; Blood-spinal cord barrier; Drug development; Neuropsychiatric diseases; Protection

Funding

  1. Fundo Europeu de Desenvolvimento Regional (FEDER) through Portugal2020 in the scope of the Operational Programme for Competitiveness and Internationalisation [POCI-01-0145-FEDER-030478, CENTRO-01-0145-FEDER-030752]
  2. Fundacao para a Ciencia e Tecnologia (FCT), Portuguese Agency for Scientific Research [POCI-01-0145-FEDER-030478, CENTRO-01-0145-FEDER-030752]

Ask authors/readers for more resources

Central nervous system (CNS) drug development faces significant difficulties that translate into high rates of failure and lack of innovation. The pathophysiology of neurological and psychiatric disorders often results in the breakdown of blood-CNS barriers, disturbing the CNS microenvironment and worsening disease progression. Therefore, restoring the integrity of blood-CNS barriers may have a beneficial influence in several CNS disorders and improve treatment outcomes. In this review, pathways that may be modulated to protect blood-CNS barriers from neuroinflammatory and oxidative insults are featured. First, the participation of the brain endothelium and glial cells in disruption processes is discussed. Then, the relevance of regulatory systems is analysed, specifically the hypothalamic-pituitary axis, the renin-angiotensin system, sleep and circadian rhythms, and glutamate neurotransmission. Lastly, compounds of endogenous and exogenous origin that are known to mediate the repair of blood-CNS barriers are presented. We believe that enhancing the protection of blood-CNS barriers is a promising therapeutic strategy to pursue in the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pharmacology & Pharmacy

Fighting Epilepsy with Nanomedicines-Is This the Right Weapon?

Mariana Matias, Adriana O. O. Santos, Samuel Silvestre, Gilberto Alves

Summary: Epilepsy is a chronic and complex neurological disease affecting approximately 50 million people worldwide. Despite the introduction of numerous new antiseizure drugs, many patients still suffer from uncontrolled seizures, necessitating the development of more effective therapies. Nanomedicine offers a promising approach to deliver drugs to the brain, enhancing their therapeutic potential. This review addresses the general features and management of epilepsy, as well as the challenges in developing better antiseizure therapies. It also discusses the role of nanomedicines in selectively delivering drugs, overcoming physical-chemical limitations, improving brain penetration, reducing adverse effects, and circumventing drug resistance.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Air-liquid interface (ALI) impact on different respiratory cell cultures

Soraia Silva, Joana Bicker, Amilca Falcao, Ana Fortuna

Summary: The intranasal route is being explored for systemic drug delivery and treatment of pulmonary and neurological diseases. The air-liquid interface (ALI) method promotes cell differentiation and optimization of airway epithelium, providing relevant input for inhalation and pulmonary toxicology. However, there is currently no consensus on the validation of the ALI method, hampering data comparison.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

Antibody and Nanobody Radiolabeling with Copper-64: Solid vs. Liquid Target Approach

Ivanna Hrynchak, Diana Cocioaba, Alexandra I. Fonseca, Radu Leonte, Sergio J. C. do Carmo, Roxana Cornoiu, Amilcar Falcao, Dana Niculae, Antero J. Abrunhosa

Summary: Antibody and nanobody-based copper-64 radiopharmaceuticals are proposed as theranostic tools in human diseases. This study discusses the production, purification, and radiolabeling of antibodies and nanobodies using copper-64 obtained from both solid and liquid targets. The liquid target method is practical and reliable, offering advantages such as speed, ease of automation, and continuous production.

MOLECULES (2023)

Article Chemistry, Multidisciplinary

Exploring the Antioxidant, Antidiabetic, and Antimicrobial Capacity of Phenolics from Blueberries and Sweet Cherries

Ana C. Goncalves, Ana R. Nunes, Sara Meirinho, Miguel Ayuso-Calles, Rocio Roca-Couso, Raul Rivas, Amilcar Falcao, Gilberto Alves, Luis R. Silva, Jose David Flores-Felix

Summary: This study analyzes the biological potential of blueberries and sweet cherries in several dimensions of human health, emphasizing the research on the benefits of consuming these fruits. Through the phenolic profile analysis of phenolic-enriched extracts from blueberries and sweet cherries, their antioxidant potential and ability to inhibit α-glucosidase enzyme activity were evaluated, along with their antimicrobial activity. The results demonstrate the significant antioxidant and antimicrobial properties of blueberries and sweet cherries, which are correlated with the presence of phenolic compounds.

APPLIED SCIENCES-BASEL (2023)

Article Pharmacology & Pharmacy

Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy

Rui Silva, Helena Colom, Joana Bicker, Anabela Almeida, Ana Silva, Francisco Sales, Isabel Santana, Amilcar Falcao, Ana Fortuna

Summary: This study aimed to develop a population pharmacokinetic (PopPK) model for perampanel in patients with refractory epilepsy. The results showed that a one-compartment model with first-order elimination best described the pharmacokinetic profiles of perampanel. Covariates such as enzyme-inducing antiepileptic drugs (EIAEDs) and body mass index (BMI) were found to significantly affect the clearance and volume of distribution of perampanel.

PHARMACEUTICS (2023)

Article Infectious Diseases

Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients

Maria Aquino, Maria Tinoco, Joana Bicker, Amilcar Falcao, Marilia Rocha, Ana Fortuna

Summary: Amikacin is the preferred antibiotic for treating Gram-negative infections in neutropenic oncology patients. However, there is a lack of population pharmacokinetic studies on amikacin in this patient population. This large-scale retrospective study investigated the effects of tumor diseases, chemotherapy, lag time, age, and renal function on amikacin pharmacokinetics in neutropenic cancer patients. The results showed that oncology patients received higher daily doses of amikacin and had increased drug clearance. Chemotherapy influenced amikacin pharmacokinetics and drug clearance decreased with longer lag time. The impact of aging on amikacin doses was stronger than chemotherapy. This research suggests that cancer patients may require higher initial doses of amikacin, especially within 30 days of starting chemotherapy.

ANTIBIOTICS-BASEL (2023)

Article Biochemistry & Molecular Biology

Synthesis, In Vitro Biological Evaluation of Antiproliferative and Neuroprotective Effects and In Silico Studies of Novel 16E-Arylidene-5α,6α-epoxyepiandrosterone Derivatives

Vanessa Brito, Mariana Marques, Marta Esteves, Catarina Serra-Almeida, Gilberto Alves, Paulo Almeida, Liliana Bernardino, Samuel Silvestre

Summary: Novel 16E-arylidene-5 alpha,6 alpha-epoxyepiandrosterone derivatives were synthesized and evaluated for their cytotoxicity and neuroprotective activity. Some of these compounds showed selective cytotoxic effects in tumoral cell lines with evidence of apoptosis activation. However, they did not demonstrate significant neuroprotection against 6-OHDA-induced neurotoxicity. Molecular docking simulations predicted a strong affinity between these compounds and 5 alpha-reductase and 17 alpha-hydroxylase-17,20-lyase enzymes.

BIOMEDICINES (2023)

Review Chemistry, Medicinal

Nanoformulations for the Delivery of Dietary Anthocyanins for the Prevention and Treatment of Diabetes Mellitus and Its Complications

Ana R. R. Nunes, Elisabete C. C. Costa, Gilberto Alves, Luis R. Silva

Summary: Diabetes mellitus is a metabolic disease characterized by abnormal blood glucose levels caused by a lack of insulin secretion or impaired insulin action. The incidence of diabetes is increasing, resulting in high healthcare costs. Current drugs have side effects, leading to kidney and liver problems. Natural compounds rich in anthocyanidins have potential for the prevention and treatment of diabetes, but their application is hindered by issues such as lack of standardization and poor stability. Nanotechnology can be used for effective delivery of these compounds.

PHARMACEUTICALS (2023)

Review Biochemistry & Molecular Biology

Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment

Jordi Olloquequi, Miren Ettcheto, Amanda Cano, Ana Fortuna, Joana Bicker, Elena Sanchez-Lopez, Cristian Paz, Jesus Urena, Ester Verdaguer, Carme Auladell, Antoni Camins

Summary: Licochalcone A (Lico-A) is a potential neuroprotective agent with various mechanisms of action, including enhancing cognitive activity, inhibiting neuroinflammation, reducing tau phosphorylation, increasing acetylcholine levels, decreasing amyloid plaques, and exerting antioxidant effects. Further research on the underlying mechanisms and targets of Lico-A may provide new insights for the treatment of cognitive disorders and neurodegenerative diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Pharmacology & Pharmacy

Nose-to-brain delivery of perampanel formulated in a self-microemulsifying drug delivery system improves anticonvulsant and anxiolytic activity in mice

Sara Meirinho, Marcio Rodrigues, Adriana O. Santos, Amilcar Falcao, Gilberto Alves

Summary: The intranasal administration of Perampanel (PER) through the olfactory pathway showed improved brain distribution and demonstrated anticonvulsant and anxiolytic effects in mice, indicating a potential alternative to oral treatment for epilepsy and anxiety. However, it also caused some neuromotor impairment, which was improved with repeated administrations. The study supports the design of clinical trials to evaluate the efficacy of intranasal PER delivery in treating neurological-related conditions.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Nasal-PAMPA: A novel non-cell-based high throughput screening assay for prediction of nasal drug permeability

Patricia Henriques, Joana Bicker, Soraia Silva, Slavomira Doktorovov, Ana Fortuna

Summary: In nasal drug product development, it is important to conduct screening studies to select promising compounds or formulations. The Parallel Artificial Membrane Permeability Assay (PAMPA) has been used to evaluate drug permeability across various barriers. This study optimized a new nasal-PAMPA model using a biorelevant medium with mucin, which accurately predicted nasal permeability and showed potential for drug and formulation screening.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Innovative Aqueous Nanoemulsion Prepared by Phase Inversion Emulsification with Exceptional Homogeneity

Patricia C. Pires, Mariana Fernandes, Francisca Nina, Francisco Gama, Maria F. Gomes, Lina E. Rodrigues, Sara Meirinho, Samuel Silvestre, Gilberto Alves, Adriana O. Santos

Summary: The aim of this study was to develop a nanoemulsion (NE) with good solubilization capacity for lipophilic drugs and the ability to promote the absorption of drugs with low permeability. Compositions containing two lipids were screened and characterized, and one composition showed high droplet size homogeneity without the need for high energy methods. Optimized compositions containing a high proportion of propylene glycol monocaprylate NF were able to solubilize simvastatin at high drug strength and promote faster intranasal absorption of the hydrophilic prodrug fosphenytoin.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Amorphous nasal powder advanced performance: in vitro/ex vivo studies and correlation with in vivo pharmacokinetics

Patricia Henriques, Joana Bicker, Andreia Carona, Margarida Miranda, Carla Vitorino, Slavomira Doktorovova, Ana Fortuna

Summary: This study investigated the application of amorphous solid dispersions (ASD) for nasal delivery, and compared two particle engineering strategies. The results showed that ASD with hydroxypropyl methylcellulose (HPMC) enhanced drug release and permeation, leading to fast drug absorption. In vitro release and ex vivo permeation studies were found to be predictive tools for nasal absorption.

JOURNAL OF PHARMACEUTICAL INVESTIGATION (2023)

No Data Available